Every year millions of cancer patients could be saved from prema­ture death and suffering if they had timely access to early detection and treatment.

World Health Organization

Onco­Lab Diag­nos­tics aims to contribute sub­stan­tially to enhanc­ing sur­vival time and qual­ity of life of can­cer patients and reduc­ing can­cer mor­tal­ity. We will achieve this by devel­op­ing, man­u­fac­tur­ing and mar­ket­ing highly inno­v­a­tive and utmost pre­cise can­cer tests.

Onco­lab Diag­nos­tics is ded­i­cated to research and devel­op­ment in close coop­er­a­tion with renowned world­wide acad­e­mia and indus­try part­ners to find new means and tech­nolo­gies to diag­nose can­cer and to characterise its specific nature.

OUR AMBITION: REDUCING THE CANCER BURDEN WITH INNOVATION

Treatment alone will not win the war on cancer: prevention and early detection are crucial.

 WHO World Cancer Report 2014

 

Despite legions of researchers trying to find appropriate diag­nostic and curative measures, overall cancer mortality could not be reduced for decades. Cur­rently, there is an urgent need for reliable non-invasive diagnostic tools.

 

OncoLab Diagnostics combines its profound expertise in the field of cancer research with the ambition to improve the lives and outlook for cancer patients. 

SKILLS & ENGAGEMENT

The OncoLab team combines profound knowledge and expertise in tumour biology, oncology and international research projects. Besides the high scientific quality, the CEO of OncoLab has long-term experience in managing and operating diagnostics enterprises as well as in developing and marketing diagnostic tests.

The Team

Contact us

OncoLab Diagnostics GmbH
TFZ - Viktor Kaplan-Straße 2, Objekt E
2700 Wiener Neustadt
AUS­TRIA

office@​oncolab.​at
www​.onco​lab​.at
Phone: +43 (0)2622 / 32913

Please enter your name.
Please enter a message.
Send
oncolab_logo_transparent_1246x281

© OncoLab Diagnostics GmbH 2019

OncoLab Diagnostics GmbH
TFZ - Viktor Kaplan-Str. 2, Bldg. E
2700 Wiener Neustadt
Austria